A Bayesian adaptive phase I/II platform trial design for pediatric immunotherapy trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Bayesian adaptive phase I/II platform trial design for pediatric immunotherapy trials

Published:2020-10-22 Issue:2 Volume:40 Page:382-402
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statistics in Medicine

Author:

Mu Rongji¹^ORCID,Pan Haitao²^ORCID,Xu Guoying³

Affiliation:

1. KLATASDS‐MOE, School of Statistics East China Normal University Shanghai China

2. Department of Biostatistics St. Jude Children's Research Hospital Memphis Tennessee USA

3. Clinical Research Center Shanghai Jiao Tong University School of Medicine Shanghai China

Funder

China Postdoctoral Science Foundation

American Lebanese Syrian Associated Charities

National Natural Science Foundation of China

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.8780

Reference45 articles.

1. MIDAS: a practical Bayesian design for platform trials with molecularly targeted agents

2. A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization

3. Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trials

4. Controlled multi-arm platform design using predictive probability

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bringing platform trials closer to reality by enabling with digital research environment (DRE) connectivity;Contemporary Clinical Trials;2024-07

2. A Bayesian latent-subgroup platform design for dose optimization;Biometrics;2024-07-01

3. Unlocking the Potential: A Systematic Review of Master Protocol in Pediatrics;Therapeutic Innovation & Regulatory Science;2024-04-23

4. Platform Trials;Bayesian Adaptive Design for Immunotherapy and Targeted Therapy;2023

5. Bringing Platform Trials Closer to Reality by Enabling with Digital Research Environment (Dre) Connectivity;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3